ストックスクリーナーアプリを入手
0.054
7.57%
0.0038
前日終値:
$0.0502
開ける：
$0.054
24時間の取引高:
504
Relative Volume:
0.04
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-25.52%
1か月 パフォーマンス:
-6.25%
6か月 パフォーマンス:
-51.35%
1年 パフォーマンス:
+102.93%
1日の値動き範囲:
$0.054
$0.054
1週間の範囲:
$0.0502
$0.072
52週間の値動き範囲:
$0.0266
$34.93
Geovax Labs Inc Stock (GOVXW) Company Profile
名前
Geovax Labs Inc
セクター
電話
678 384 7220
住所
1900 Lake Park Drive, Suite 380, Smyrna
GOVXW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOVXW
Geovax Labs Inc
|
0.054 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Geovax Labs Inc (GOVXW) 最新ニュース
Short Interest in GeoVax Labs, Inc. (NASDAQ:GOVX) Drops By 12.3% - Defense World
GeoVax Labs CEO Makes Bold Stock Purchase! - TipRanks
Geovax labs CEO David Dodd acquires $10,800 in common stock - Investing.com India
Geovax Labs stock hits 52-week low at $1.09 amid market challenges - Investing.com
Roth Capital Forecasts GeoVax Labs FY2029 Earnings - Defense World
GeoVax Labs (NASDAQ:GOVX) Earns Buy Rating from D. Boral Capital - Defense World
GeoVax Labs Advances Vaccine Trials and Expands Operations - TipRanks
GeoVax Labs Earnings Call: Mixed Sentiments and Strategic Plans - TipRanks
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update - TradingView
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges By Investing.com - Investing.com South Africa
GEOVAX LABS Earnings Results: $GOVX Reports Quarterly Earnings - Nasdaq
GeoVax Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges - Investing.com
What's Next: Geovax Labs's Earnings Preview - Benzinga
GEOVAX LABS Earnings Preview: Recent $GOVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
GeoVax Labs IncEnters Placement Agency And Securities Purchase Agreements With A.G.P./Alliance Global PartnersSEC Filing - MarketScreener
GeoVax Labs Inc expected to post a loss of 77 cents a shareEarnings Preview - TradingView
GeoVax Prepares to Announce Fourth Quarter and Full Year 2024 Financial Results - citybuzz -
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025 - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Given Average Recommendation of “Buy” by Analysts - Defense World
International - Financial Content
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK - Yahoo Finance
GeoVax CEO to Present at 37th Annual Roth Conference, Highlighting COVID-19 Vaccine and Cancer Therapy Research - citybuzz -
GeoVax to Present at the 37th Annual Roth Conference - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Short Interest Up 35.5% in February - Defense World
News - Financial Content
Geovax Labs Inc (NASDAQ: GOVX) Could Fell Another -164.9% - Stocks Register
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy - Yahoo Finance
GeoVax Labs’ (GOVX) “Buy” Rating Reiterated at D. Boral Capital - Defense World
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern - Yahoo Finance
GeoVax Labs (GOVX) Projected to Post Earnings on Thursday - Defense World
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness - Yahoo Finance
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Rating of “Buy” from Analysts - Defense World
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health - Yahoo Finance
GeoVax shareholders approve warrant exercises - MSN
GeoVax to Highlight Mpox Vaccine Development at Emerging Growth Conference - citybuzz -
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award - Yahoo Finance
Was Geovax Labs Inc (GOVX)’s session last reading good? - US Post News
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs - Financial Content
Stock Surge: Geovax Labs Inc (GOVX) Closes at 1.77, Marking a -7.33 Increase/Decrease - The Dwinnex
Analysts review Geovax Labs Inc’s rating - Knox Daily
GeoVax to Present Strategic Vision for Cancer and Infectious Disease Treatments at Major Biotech Conference - citybuzz -
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference - Yahoo Finance
Trump's Stargate Initiative: A New Era For Healthcare Innovation - Evrim Ağacı
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative - Yahoo Finance
GeoVax Labs (NASDAQ:GOVXW) Shares Down 11.3% – Here’s Why - Defense World
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability - Yahoo Finance
GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide - Yahoo Finance
Geovax Labs Inc (GOVXW) 財務データ
Geovax Labs Inc (GOVXW) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.89%
0.13%
大文字化:
|
ボリューム (24 時間):